Published in Sci Rep on February 08, 2017
The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics. Antioxidants (Basel) (2017) 0.75
Mitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells. Cell Metab (2017) 0.75
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science (2005) 38.99
AKT/PKB signaling: navigating downstream. Cell (2007) 31.26
The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer (2002) 28.11
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer (2007) 14.84
Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol (2009) 13.89
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell (2009) 5.97
mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem (2005) 5.62
Guilty as charged: B-RAF is a human oncogene. Cancer Cell (2004) 4.97
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J (2008) 4.49
Structural basis of mitochondrial tethering by mitofusin complexes. Science (2004) 4.21
mTOR and cancer: many loops in one pathway. Curr Opin Cell Biol (2009) 3.22
Sequence mutations and amplification of PIK3CA and AKT2 genes in purified ovarian serous neoplasms. Cancer Biol Ther (2006) 2.76
Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol (2004) 2.75
mTOR signaling in disease. Curr Opin Cell Biol (2011) 2.73
mTOR complex 2 signaling and functions. Cell Cycle (2011) 2.66
Common corruption of the mTOR signaling network in human tumors. Oncogene (2008) 2.60
TOR complex 2: a signaling pathway of its own. Trends Biochem Sci (2009) 2.05
mTOR Signaling. Cold Spring Harb Perspect Biol (2012) 1.79
mTOR signaling in glioblastoma: lessons learned from bench to bedside. Neuro Oncol (2010) 1.65
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment. Nature (2016) 1.50
Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science (2015) 1.47
Loss of PTEN expression followed by Akt phosphorylation is a poor prognostic factor for patients with endometrial cancer. Endocr Relat Cancer (2003) 1.43
Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci U S A (2013) 1.42
Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res (2007) 1.39
Mutational analysis of action of mitochondrial fusion factor mitofusin-2. J Cell Sci (2005) 1.22
Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res (2012) 1.16
Mammalian target of rapamycin (mTOR) signaling network in skeletal myogenesis. J Biol Chem (2012) 1.13
Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics. Mol Ther (2007) 1.08
Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features. Neuropathology (2009) 1.04
Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells. Med Oncol (2010) 0.98
Anti-tumor effects of Mfn2 in gastric cancer. Int J Mol Sci (2013) 0.97
Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol (2010) 0.97
The role of hypertension-related gene in aortic vascular smooth muscle cells from mice and rats. Chin Med J (Engl) (2001) 0.84
Metabolic Stress-Induced Phosphorylation of KAP1 Ser473 Blocks Mitochondrial Fusion in Breast Cancer Cells. Cancer Res (2016) 0.79
Inhibitory effect of miR-184 on the potential of proliferation and invasion in human glioma and breast cancer cells in vitro. Int J Clin Exp Pathol (2015) 0.79
Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells. Int J Clin Exp Pathol (2015) 0.78